PegBio (HKG:2565) said the China Securities Regulatory Commission has issued a filing notice for its Hong Kong share full circulation application, according to a Thursday bourse filing.
Shares of the biotechnology company were up nearly 1% in Friday morning trade.
The filing covers the conversion of about 101.7 million unlisted shares into Hong Kong shares.
PegBio will apply to the Hong Kong stock exchange for the listing of the converted shares, with further details of the plan yet to be finalized.